Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  CardiovascularIssue 730

AACE: Prediabetes Guidelines for Lipids and Blood Pressure Levels

Call for guidelines for prediabetes from the Clinical Endocrinologists meeting....

Advertisement

While the American Association of Clinical Endocrinologists (AACE) guidelines for diabetes prevention offer an HbA1c goal of normoglycemia when a patient is in the range of prediabetes, AACE presented a call for additional guidelines in lipids and blood pressure when treating patients with prediabetes.

Leigh Perreault, MD, associate professor of medicine at the University of Colorado Anschutz Medical Campus, stated during her presentation at the AACE 23rd Annual Scientific & Clinical Congress that, currently, "there are no guidelines anywhere for exactly what our goals should be for lipids or for blood pressure for these people." "We should come together as a community to create these guidelines because there are so many people out there who could probably benefit."

Perreault presented extensive data supporting the AACE guidelines that instruct physicians to aim for normoglycemia in patients with prediabetes. The Diabetes Prevention Program, she explained, showed that when patients in the range of prediabetes returned to normoglycemia at any given point over the 10 years of observation, their risk of transitioning to diabetes was reduced. If they returned to normoglycemia more than once, they further reduced their risk.

"If we set that goal as normal glucose regulation, we can reduce their risk tremendously, up to 70% for people in whom we can actually get them there and keep them there," Perreault said."The good news from this analysis is it didn't matter how people got to normal, as long as people got to normal. This is a change, a shift in our paradigm, a rethinking of diabetes care or diabetes prevention."

This shift should also encompass reducing the cardiovascular risk of these patients with prediabetes, she said.

"There are data showing we can reduce cardiovascular risk factors and cardiovascular risk in people with prediabetes by treating them," Perreault said. "People can get complications of diabetes even if they never develop diabetes. People with prediabetes can get these complications. And the prevention of diabetes, particularly if [normoglycemia] can be achieved, is key and the risk reduction of cardiovascular disease might be right behind it."

Therefore, there is need to consider the lipid profile and blood pressure levels and create guidelines for the best management of patients with prediabetes.

Perreault L. W22. Presented at: AACE 23rd Annual Scientific & Clinical Congress; May 13-18, 2014; Las Vegas, Nevada.  

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 23 May, 2014 and appeared in  CardiovascularIssue 730

Past five issues: Issue 766 | Diabetes Clinical Mastery Series Issue 225 | Issue 765 | Diabetes Clinical Mastery Series Issue 224 | Issue 764 |

2015 Most Popular Articles:

Significant Weight Loss and Drop in A1c with New Combo of Lorcaserin and Phentermine
Posted January 16, 2015
ADA Issues New Standards of Medical Care for Diabetes
Posted January 02, 2015
New Guideline Released on Pharmacological Management of Obesity
Posted January 23, 2015
For Your Patients: Practical Advice to Rev Up Your Workouts and Lower Fatigue
Posted January 09, 2015
Dr. Timothy Garvey on Qsymia and Other New Therapies for Weight Loss
Posted January 12, 2015
Phentermine and Topirimate ER (Qsymia) Studied for Type 2 Diabetes Patients
Posted January 15, 2015
Handbook of Diabetes, 4th Ed., Excerpt #25: Specific Circumstances that Affect Diabetes Control
Posted January 04, 2015
New Insulin Glargine 300 Effective in Type 1 Diabetes
Posted January 16, 2015
FDA Approves Maestro Electronic Weight Loss Device
Posted January 23, 2015
New Guidelines Recommend Off-Loading to Increase Likelihood of Diabetic Foot Ulcer Healing
Posted December 26, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Will you prescribe inhaled insulin (Afrezza) when it becomes available this year?
CME/CE of the Week
Marie Williams, DPM

Category: Wound Care
Credits: .75



Search Articles On Diabetes In Control